JPS58760A - Separation of catabolic hemoglobin - Google Patents

Separation of catabolic hemoglobin

Info

Publication number
JPS58760A
JPS58760A JP56099451A JP9945181A JPS58760A JP S58760 A JPS58760 A JP S58760A JP 56099451 A JP56099451 A JP 56099451A JP 9945181 A JP9945181 A JP 9945181A JP S58760 A JPS58760 A JP S58760A
Authority
JP
Japan
Prior art keywords
monomer
hemoglobin
catabolic
polymerizable
copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56099451A
Other languages
Japanese (ja)
Other versions
JPH0115024B2 (en
Inventor
Fumio Kamiyama
文男 神山
Minoru Obara
実 小原
Mitsuo Nagata
永田 光男
Yasuhiko Araki
泰彦 荒木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP56099451A priority Critical patent/JPS58760A/en
Priority to US06/371,491 priority patent/US4468330A/en
Priority to EP82302134A priority patent/EP0063947B1/en
Priority to DE8282302134T priority patent/DE3276929D1/en
Priority to CA000401649A priority patent/CA1203944A/en
Publication of JPS58760A publication Critical patent/JPS58760A/en
Publication of JPH0115024B2 publication Critical patent/JPH0115024B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

PURPOSE:To separate and determine catabolic hemoglobin in high accuracy, by using a copolymer constituting of a specific rate of three kinds monomers, each having the hydrophobic parameter lower than the specific value, of a monomer having COOH radical in a molecule less than a specific value, a cross-linking polymeric monomer and a monomer not containing COOH as packings. CONSTITUTION:The fine particles of a copolymer copolymerized three kinds of monomers, each having <=2.3 hydrophobic parameter are used for packings of liquid chromatography. That is, copolymer particles constituted by 5-95wt% monomer A having >=one COOH radical and one polymeric double bond, 10- 95wt% cross-linking monomer B having >=2 polymeric double bond and 0- 85wt% monomer C which is other than the group A and having one polymeric double bond are obtained by crushing after said copolymer is obtained by a suspension polymerization method or bulk polymerization method. Catabolic hemoglobin in blood serum of a diabetic etc. is separated and is determined in a short time in high accuracy by using this particle as packings.

Description

【発明の詳細な説明】 本発明は血液中のヘモグロビンとくに異化ヘモグロビン
を診断等のために分離定量する方法Kllするものであ
る。成人のヘモグロビン(以下IIIと略す)#i分子
量的s 亀o o oの蛋白質で、4個のへふが1個の
グロビン蛋白に結合し丸形で存在している。ところがア
ルカリ性のPH(PIIILli)の条件下で正常ヒ)
Hbを電気&#させると90〜9s−を占めるHb、す
なわちHbAoのmK、該HbAoよりも移動度が少し
遅れてHbF及びHbAlcが、さらに遅れてHbAl
a%HbA1 b等が分離され、これらの存在が認めら
れている。さらK、より精密な電気激動試験等の結果か
ら、HbAld。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for separating and quantifying hemoglobin in blood, particularly catabolic hemoglobin, for purposes such as diagnosis. Adult hemoglobin (hereinafter abbreviated as III) is a protein with a molecular weight of s o o o, and exists in a round shape with four hemoglobins bound to one globin protein. However, under conditions of alkaline pH (PIIILli)
When Hb is subjected to electricity &
a%HbA1 b, etc. have been separated and their existence has been recognized. Furthermore, from the results of more precise electrical turbulence tests, HbAld.

HbAlc勢の存在もamされている。これら異常ヘモ
グロビンを正常ヘモグロビン(HbAo)K比して、蛋
白の一次構造が遮っているものか戚いFiHh A o
 K 111が化合しているもの吟である。これらの異
化ヘモグロビンの分離定量は種々の病気O@謙指標とし
て重要であることが分っており、例えばHbFの定量は
遺伝性高HbF症の診断に不可欠であり、またHbAI
Cの増減のチェックは着駅病の治療に欠かせない。又、
Hb Amと称される腋分けHbFと同様に遺伝性のも
のであり、さらにアセチル化ヘモグロビン(Ac、l1
b)と称される異常ヘモグロビン社アセチル基を有する
薬剤例えばアスピリン等の服用により生成することが判
明してきてお傍、これらの異化ヘモグロビンの分離定量
は医学的な見地からしてますます重要性の度合が高まっ
ている。
The presence of HbAlc groups has also been demonstrated. By comparing these abnormal hemoglobins with normal hemoglobin (HbAo), we can determine whether the primary structure of the protein is blocking the protein or whether it is related to FiHhAo.
It is a compound containing K111. Separation and quantification of these catabolic hemoglobins is known to be important as an indicator for various diseases.For example, quantification of HbF is essential for the diagnosis of hereditary hyperHbF syndrome, and HbAI
Checking the increase or decrease of C is essential for the treatment of stationary disease. or,
It is hereditary like HbF, which is called Hb Am, and is also inherited by acetylated hemoglobin (Ac, l1
Abnormal hemoglobins called b) have been found to be produced by taking drugs with acetyl groups, such as aspirin, and the separation and quantification of these catabolic hemoglobins is becoming increasingly important from a medical perspective. The degree of this is increasing.

しかしながら現在までに1上記の様な異化へ毫グaビン
を短時間で精度よく分離、定量することO出来る方法F
i提案されていなかった。
However, to date, there have been no methods available for separating and quantifying the catabolic substances mentioned above in a short time and with high precision.
i It wasn't suggested.

本発明は上記の如き現状Kかんがみ、異化へ毫グロビン
を精度よくしかも短時間に分離、定量することの出来る
方法を提供することを目的としてなされたものであり、
その要旨は、分子中に1個の重合性2重結合と1個以上
のカルボキシル基を有し、疎水性ノ嘴ラメ−クーが23
以下の重合性モノマー■5〜90重量哄、分子中に2個
以上の重合性2重結合を有しかつ疎水性パラメーターが
23以下の架橋腫合性モノt−@lO〜95重量哄、分
子中に1個の重合性2重結合を有し疎水性ノ(ラメ−タ
ーがz3以下にして上記重合性七)で−囚とけ興なるモ
ノ9−c)O〜畠5菫量哄から々るモノマー混合物が共
重合されてなる親水性イオン交換体を固定相とする波体
クロマトグラフィーによって行われることを特徴とする
異化ヘモグロビンの分離法に存する。
In view of the current state of affairs as described above, the present invention has been made with the object of providing a method capable of separating and quantifying catabolic globin with high precision and in a short time.
Its gist is that it has one polymerizable double bond and one or more carboxyl groups in the molecule, and has a hydrophobic beak of 23
The following polymerizable monomers: 5 to 90 parts by weight, a cross-linked tumorigenic monomer having two or more polymerizable double bonds in the molecule and a hydrophobicity parameter of 23 or less t-@lO to 95 parts by weight, molecule It has one polymerizable double bond in it and is hydrophobic (with a ramester of z3 or less and the above polymerizability 7) - a monomer that can be dissolved 9-c) from O to Hatake 5. A method for separating catabolic hemoglobin, characterized in that it is carried out by wave body chromatography using a hydrophilic ion exchanger as a stationary phase, which is a copolymerized monomer mixture.

本発明においては特定の組成のモノイー混合物が共重合
されてなる親水性イオン交換体が、液体クロマトグツフ
ィーの固定相として用いられるのである。そして上記共
重合されたイオン交換体を固定相すなわち充填剤として
用いるには、例えば共重合によ抄得られた共重合体粒子
を粒径を揃える等してそOま\充填剤として用いてもよ
く、バルク重合の場合は共重合体を粉砕したものを粒径
を揃えて用いて本よく、又けがクス球等の適宜な芯材の
表面に上記共重合体を適宜な方法でコーティングしたも
のを用いてもよい。
In the present invention, a hydrophilic ion exchanger formed by copolymerizing a monoe mixture with a specific composition is used as a stationary phase for liquid chromatography. In order to use the above-mentioned copolymerized ion exchanger as a stationary phase, that is, a filler, for example, the copolymer particles obtained by copolymerization may be made to have a uniform particle size, and then used as a filler. In the case of bulk polymerization, pulverized copolymers with the same particle size may be used, or the surface of an appropriate core material such as a plastic ball may be coated with the above copolymer by an appropriate method. You may also use

しかして本発明充填剤を構成する共重合体は、分子中に
1個の重合性2重結合と1個以上のカルボキシル基を有
し疎水性パラメーターが23以下の菫合性七ツマー囚が
S〜90重量哄重量子中に2個以上の重合性211結合
を有しかつ疎水性ノ曵りメ一クーが!3以下の架橋重合
性モノマー(2)が10〜9s重量囁、分子中に1個の
重合性2重結合を有し疎水性パラメーターがz3以下に
して上記重合性七ツマ−(4)とけ異なるモノマー幻が
O〜85重量哄からなるモノマー混合物が共重合され喪
ものであり、この共重合には懸濁重合、エマルジョン重
合、溶液重合、バルク重合等の従来において行われてい
る重合法が採用可能であるが、重合体粒子をそのま\充
填剤として用いることが出来る点で懸濁重合法が好適で
ある。又、懸濁重合の際に、七ツマ−は溶解するが重合
体を溶解しない有機溶剤を少量加えておけば生成した共
重合体粒子は多孔質のものとなり、移動相との接触面積
が増大した充填剤が得られる。
However, the copolymer constituting the filler of the present invention has one polymerizable double bond and one or more carboxyl groups in the molecule, and has a hydrophobicity parameter of 23 or less. It has two or more polymerizable 211 bonds in ~90 weight molecules and is hydrophobic! The crosslinking polymerizable monomer (2) of 3 or less has a weight of 10 to 9 seconds, has one polymerizable double bond in the molecule, and has a hydrophobic parameter of z3 or less, which is different from the above polymerizable monomer (4). A monomer mixture consisting of 0 to 85 parts by weight of monomers is copolymerized, and conventional polymerization methods such as suspension polymerization, emulsion polymerization, solution polymerization, and bulk polymerization are used for this copolymerization. Although this is possible, suspension polymerization is preferred because the polymer particles can be used as they are as a filler. Additionally, if a small amount of an organic solvent is added during suspension polymerization, which dissolves the polymer but does not dissolve the polymer, the resulting copolymer particles will become porous, increasing the contact area with the mobile phase. A filler containing a mixture of

S− ここで疎水性ノqラメ−ターとけ成る化合物のオクチル
アルコール−水系への溶解度比の対数であり、その化合
物特有の値である。そして該パラメーターは実験によっ
ても求められるが、分子中の各72グメントの寄与(1
1m水性7ラグメント定数)が計算によって求められる
ことが出来、これらの総和としてその化合物の疎水性/
鴫りメーター値が算出できる、。
S- Here, it is the logarithm of the solubility ratio in the octyl alcohol-water system of a compound that differs from the hydrophobic q-rameter, and is a value specific to that compound. The parameters can also be found through experiments, but the contribution of each 72 segment in the molecule (1
1m aqueous 7 fragmentation constant) can be obtained by calculation, and as a summation of these, the hydrophobicity/
You can calculate the haze meter value.

疎水性/4フメーター値の計算法については、RmF4
ekk@r  著 rThe  Hydrophobl
c  FragmentalConstant J(E
lsevier 5cieatifle Publis
hingCo、11177年発行)の第3章に述べられ
ており、本発明におけるパフメーター値はこの計算法に
基づいている。
For the calculation method of hydrophobicity/4F meter value, please refer to RmF4
Written by ekk@r rThe Hydrophobl
c FragmentalConstant J(E
lsevier 5cieatifle Publicis
hingCo, 11177), and the puff meter values in the present invention are based on this calculation method.

次に本発明において好適に用いられる重合性七ツマ−(
2)としてけアクリに@CIIL水ノ曵ラメータう−−
13、以下括弧内は/唯うメーター値を示す)、メタク
リル酸(−19)、クロトン酸(−19)、マレインI
I(−翫7)等が挙けられる。
Next, the polymerizable heptamer (
2) @CIIL Mizunohira Meter to Toke Akuri ---
13. The following values in parentheses indicate meter values), methacrylic acid (-19), crotonic acid (-19), maleic acid
Examples include I(-翫7).

6− 又、本発明に用いられる架橋重合性モノマー混合物とし
て社テトラメチロールメタントリアクリレ−)(−α7
3)、テトラメチロールメタントリツタクリレート((
LISI)、テトラメチロールメタンジアクリレート(
−170)、テトラメチロールメタンジメタクリレート
(α82)、テトラメチロールメタンテトラアクリレー
ト(α24)、テトラメチロールメタンテトラメタクリ
レート(α20)、)リメチロールエタントリアクリレ
ート(α88)、)リメチロールエタントリメタクリレ
ート(240)、ジベ>pエリスリトールヘキサアクリ
レート(−(LISI)等が挙げられ、その他テトラエ
チレングリコールジメタクリレート(−(L30)など
のポリエチレングライコールジアクリレート(又はメタ
クリレート)やポリエチレングライコールジアクリレー
ト(又はメタクリレート)411のアルキレングライコ
ールジアクリレート(又はメタクリレート)も使用出来
る。
6- Also, as the crosslinking polymerizable monomer mixture used in the present invention, Tetramethylolmethane triacrylate (-α7)
3), Tetramethylolmethanetritsutaacrylate ((
LISI), tetramethylolmethane diacrylate (
-170), Tetramethylolmethane dimethacrylate (α82), Tetramethylolmethanetetraacrylate (α24), Tetramethylolmethanetetramethacrylate (α20), ) Limethylolethane triacrylate (α88), ) Limethylolethane trimethacrylate (240) , dibe>p erythritol hexaacrylate (-(LISI)), and other polyethylene glycol diacrylate (or methacrylate) such as tetraethylene glycol dimethacrylate (-(L30)) and polyethylene glycol diacrylate (or methacrylate) 411 Alkylene glycol diacrylate (or methacrylate) can also be used.

又、前記モノマー囚とけ異なる七ツマー0#−i太発1
9iにおいて必要に応じて85重量哄の量的範囲まで用
いることが出来るのであるが、該七ツマ一つとしてtf
NN−ジメチルメタアクリルアミド(−〇〇8)、2−
ヒドロキシエチルメタアクリレート(−α41)、グリ
シジルメタアクリレート(−α48)などが好適に用い
られ、その他NN−ジメチルアクリルアミド、2−ヒド
ロキシエチルアクリレート、グリシジルアクリレートな
ども使用出来る。
Moreover, the monomer capacitors are different from each other.
In 9i, it is possible to use up to a quantitative range of 85 kg as needed, but as one of the seven parts, tf
NN-dimethylmethacrylamide (-〇〇8), 2-
Hydroxyethyl methacrylate (-α41), glycidyl methacrylate (-α48), etc. are preferably used, and NN-dimethylacrylamide, 2-hydroxyethyl acrylate, glycidyl acrylate, etc. can also be used.

本発明においては上述の如く、重合性モノマー囚5〜9
01量哄、架橋重合性モノマー@10〜95菫量哄から
なるモノマー混合物若しくけ必要KI15じて前記モノ
マ一つが85重量哄まで加えられ九七ツマー混合物が共
重合されるのであるが、得られた共重合体はカルボキシ
ル基を有する重合性モノマー(2)が分子中に存在する
ことKよりそれ自体イオン交換作用を示すイオン交換体
となる。そしてモノマー混合物において、カルボキシル
基を有する!官能性のモノマー■が少なすぎるとイオン
交換能が低下するのでモノマー囚は5重量哄以−ヒが必
要とされるのであ秒、又、2個以上の重合性2型詰杏を
有する架橋重合性モノマー(2)の量が少なすぎると共
重合体中の架橋結合の密度が減じ、とくに高速波体クロ
マトグラフ用充填剤として用いられた際、高圧に対抗す
るための機械的強度に問題が生じるので該モノマー@H
IO重量哄以上が必要とされるのである。又、前記重合
性モノマー囚以外の重合性2重結合を有するモノマーゆ
け、重合性モノマー(2)及び架橋重合性モノマー■の
使用割合が必要量より少くならない範囲で混合モノマー
中に含まれることが出来る。
In the present invention, as mentioned above, polymerizable monomer particles 5 to 9
A monomer mixture consisting of 0.1 volume of a cross-linking polymerizable monomer @ 10 to 95 volume of a monomer is then copolymerized by adding one of the monomers up to 85 volume of a cross-linking polymerizable monomer @ 10 to 95 volume of a monomer mixture. The resulting copolymer itself becomes an ion exchanger exhibiting an ion exchange action because the polymerizable monomer (2) having a carboxyl group is present in the molecule. And in the monomer mixture, it has a carboxyl group! If the amount of functional monomer (2) is too small, the ion exchange ability will be reduced, so a monomer weight of 5 weight or more is required. If the amount of the monomer (2) is too small, the density of crosslinks in the copolymer will decrease, causing problems in mechanical strength to withstand high pressure, especially when used as a packing material for fast wave chromatography. Since the monomer @H
More than IO weight is required. In addition, monomers having a polymerizable double bond other than the above-mentioned polymerizable monomers, polymerizable monomer (2), and crosslinking polymerizable monomer (2) may be included in the mixed monomer to the extent that the proportion used does not become less than the required amount. I can do it.

本発明に用いられる親水性イオン交換体を共重合により
生成するモノマー混合物中に含着れるモノマーはいずれ
も疎水性/へツメ−ターが23以下となされるのである
が、これは、疎水性ノqクメーターがzs以下の七ツマ
−が共重合されたイオン交換体からなる充填剤が異化ヘ
モグロビンの分析においてすぐれた分離能を示すという
本発明の知見にもとづくものであり、例え−9− は従来からイオン交換体を製造するために架橋重合性七
ツマ−として常用されて米たジビニルベンゼンは疎水性
パラメーターが18と高いので、これが共重合成分とし
て含まれるイオン交換体を充填剤として用いても未発明
の効果を奏し得ないのである。又、前記重合性モノマー
囚、架橋重合性七ツマ−(6)及び必要に応じて加えら
れるそツマーcsct*水性l(ラメ−ターがθ以下か
マイナス側にあるのが本発明における分析時に分析物質
の充填剤への吸着を防止する点で好ましい・ 上記親水性イオン交換体は常法によりカラムに充填され
て、液体クロマトグラフによる未発明の分11に用いら
れるのであり、そのIIKけイオン交換機構にもとづく
分析挙動を示す。
All monomers contained in the monomer mixture produced by copolymerizing the hydrophilic ion exchanger used in the present invention have a hydrophobicity/hetometer of 23 or less; This is based on the knowledge of the present invention that a packing material made of an ion exchanger copolymerized with a 7-mer with a q-meter of zs or less exhibits excellent separation ability in the analysis of catabolic hemoglobin. Divinylbenzene, which is commonly used as a crosslinking polymerizable hexamer to produce ion exchangers, has a high hydrophobicity parameter of 18, so even if an ion exchanger containing this as a copolymerization component is used as a filler. It is impossible to achieve the effects of an uninvented invention. In addition, the polymerizable monomer particles, the cross-linked polymerizable hexamer (6), and the additive added as necessary csct This hydrophilic ion exchanger is preferred in terms of preventing adsorption of substances to the packing material.The above hydrophilic ion exchanger is packed into a column by a conventional method and used for liquid chromatography. Demonstrates analytical behavior based on mechanism.

本発明による分離け、上記親水性イオン交換体が充填さ
れたカラムを筐体クロマトグラフ好ましくけ高遮練体り
ロマトグクフに接続し、それ以後社液体クロマトグラフ
による分離、定量の手法Kl!つて試料である血液を該
クロマトグー1)− ラフに注入し、溶離液を流す等の操作により行うことが
出来る。分離の対象となる異化ヘモグロビンの種類や使
用するカラム充填剤の種類によって最適な溶離条件が決
定さるべきであるが、又、分離操作中KPMやイオン強
度を変化させる手法によって種々の異化ヘモグロビンを
良好に分離、定量することが出来る。又、検出は波長4
15nmの可視光を用いて行うのが好ましい。
In the separation according to the present invention, the column packed with the above-mentioned hydrophilic ion exchanger is connected to a housing chromatograph, preferably a highly insulating body, and then separated and quantified using a liquid chromatograph. This can be performed by injecting blood as a sample into the chromatograph 1) and flowing the eluent. The optimal elution conditions should be determined depending on the type of catabolic hemoglobin to be separated and the type of column packing material used, but it is also possible to obtain favorable elution conditions for various catabolic hemoglobins by changing KPM and ionic strength during the separation operation. can be separated and quantified. Also, detection is at wavelength 4.
It is preferable to use visible light of 15 nm.

又、異化ヘモグロビンの溶出順序は一般に殆んどl!酌
せずに、BbAIa、HbAIb、Hb F 、 Hb
 A 1 c 、IHb A o 、 Hb Asの順
となるが、溶離操作において溶離条件を変化させるとと
Kよって、特定の異化ヘモグロビンを良好々クロマトグ
ラフビークとして出現させ、他の具化へそグロビンや正
常ヘモグロビン汀分離が良好でない壇とまったピークと
して出現させて目的2する異化ヘモグロビンの定量を短
時間で効果的に行うことも可能である。
Also, the elution order of catabolic hemoglobin is generally almost l! Without consideration, BbAIa, HbAIb, Hb F, Hb
The order is A 1 c , IHb A o , and Hb As. However, if the elution conditions are changed during the elution operation, a specific catabolic hemoglobin will appear as a good chromatographic peak, and other embodied umbilical globins and It is also possible to effectively quantify catabolic hemoglobin in a short period of time by causing it to appear as a stationary peak with poor separation of normal hemoglobin.

本発明は上述の通りの異化ヘモグロビンの分離法てあり
、とくに特定組成の七ツマー混合物が共菫合されてなる
親水性イオン交換体が固定相として用いられ、該固定相
は分離性能と共に強度的にもすぐれているので高速液体
クロマドグ27用充填剤として用いることが可能でおり
、本発明によれば異化ヘモグロビンを精度よくしかも短
時間に分離、定量することが出来るというすぐれた効果
を奏するのである。
The present invention provides a method for separating catabolic hemoglobin as described above, and in particular, a hydrophilic ion exchanger formed by copolymerizing a heptamer mixture with a specific composition is used as a stationary phase, and the stationary phase has both separation performance and strength. Because of its excellent properties, it can be used as a packing material for high-performance liquid chromadog 27. According to the present invention, catabolic hemoglobin can be separated and quantified with high precision and in a short time, which is an excellent effect. .

以下本発明の実施例にりいて説明する。The present invention will be explained below with reference to examples.

実施例1 冷却機、攪拌機、温度計および滴下ロートの設置された
2tのセパラブルフラスコに4重量%のポリビニルアル
コール水溶液400m、テトラエチレングリコールジメ
タクリレート4゜t1テトツメチロールメ多ンドリアク
リレート16t、メタクリル酸50F、)ルエン40?
およびベンゾイルパーオキサイドLIFよりなる混合液
を供給した。次K 4 G Or p mの攪拌速度で
攪拌しながら1lOtl:に昇温し10時時同応を行っ
て冷却した。冷却後重合生成を母液分離し良後、熱水お
よびアセトンで洗滲して粒子径が5〜20ミクロンの球
状ポリマーを得た。
Example 1 In a 2 t separable flask equipped with a cooler, stirrer, thermometer and dropping funnel, 400 ml of 4% by weight aqueous polyvinyl alcohol solution, 4°t of tetraethylene glycol dimethacrylate, 16 t of tetraethylene glycol dimethacrylate, 16 t of methacrylic acid were added. acid 50F,) luene 40?
and benzoyl peroxide LIF were supplied. Next, the temperature was raised to 1 lOtl while stirring at a stirring speed of K 4 G Or p m, and the same reaction was carried out at 10 o'clock, followed by cooling. After cooling, the polymerization product was separated from the mother liquor and washed with hot water and acetone to obtain a spherical polymer having a particle size of 5 to 20 microns.

そのうち微粒子および粗粒子を取除いて得られ九S〜1
2ミクロンの粒子を80−のイオン交換水に分散し、ス
テンレスカラム(直径7.9■、長さ30 m ) K
高圧定流量ポンプにより上記イオン交換水を16−7分
の速度で圧送する仁とKよ艶充填した。得られ九充填カ
ラムを高速波体クロマトグラブ(商品名:島津デュポン
高速波体クロ7トグラフ8308りK接続して以下の分
析操作を行った。
Of these, fine particles and coarse particles are removed to obtain 9S~1
Particles of 2 microns were dispersed in 80-degree ion-exchanged water, and a stainless steel column (diameter 7.9 mm, length 30 m) K
The ion-exchanged water was pumped at a rate of 16-7 minutes using a high-pressure constant flow pump to fill the container. The resulting 9-packed column was connected to a high-speed wave chromatograph (trade name: Shimadzu DuPont High-Speed Wave Chromatograph 8308), and the following analytical operations were performed.

試料として正常人及び糖尿病患者のそれぞれの血液50
pLをlccのイオン交換水と混合して溶血させたヘモ
グロビン溶液1oPtをミクロシリンジにより注入して
分析を行った。溶離液としてけalNリン酸2ナトリク
ム水溶液30哄とalNリンl11カリクム水溶1[7
0%との混合液をA液(PRa5)とし、B波とし13
− てA竣に3哄になるようKNaCl、を溶解させた水溶
液を用いた。
50 samples of blood each from a normal person and a diabetic patient
Analysis was performed by injecting a hemoglobin solution 1oPt, which was prepared by mixing pL with ion-exchanged water of lcc and causing hemolysis, using a microsyringe. As the eluent, 30 liters of an aqueous solution of disodium alN phosphate and 1 liter of an aqueous solution of alN phosphoric acid 1 [7
The mixed solution with 0% is called A solution (PRa5), and the B wave is called 13
- An aqueous solution in which KNaCl was dissolved to a total of 3 liters was used.

A波100哄で溶離を開始し、B掖を5%/1分の割合
で増加させる様にした。得られたクロマトグツムを第1
図に示す。なお検出は415amの可視党検出機を用い
た。
Elution was started with an A wave of 100 drops, and the B wave was increased at a rate of 5%/1 minute. The obtained chromatogum is the first
As shown in the figure. The detection was carried out using a 415 am visible party detector.

次に1この分野でよく知られている液体クロマトグラフ
ィー用充填剤(Biorex−70、バイオラッド社(
米)製)を用いるイオン交換カラムクロマトグラフィー
によって、Alm、Alb。
Next, 1 well-known liquid chromatography packing material in this field (Biorex-70, Bio-Rad Co., Ltd.
Alm and Alb were obtained by ion exchange column chromatography using a commercially available product (manufactured in USA).

A I C* A O各成分を約z時開以上かけて分画
し、それぞれの分画成分について前記条件で本発明によ
る高速液体クロマトグラフ分析を行って、第1図のクロ
マトグツムのピーク1〜7の同定を行ったところ、A1
a%A1bx ^1c、A(1及びム、tfそれぞれ、
2,3.5.6及び7のピークに一致することが分った
。又、ビークlFi非ヘモグロビン成分であろうと思わ
れる。
A I C * A O Each component was fractionated over a time period of about z or more, and each fractionated component was subjected to high performance liquid chromatography analysis according to the present invention under the above conditions, and the peaks 1 to 1 of the chromatograms in FIG. 7 was identified, A1
a%A1bx ^1c, A (1 and mu, tf respectively,
It was found that the peaks corresponded to No. 2, 3, 5, 6, and 7. It is also believed that the beak lFi is a non-hemoglobin component.

又、ピーク4tiHbFであることが殆児由米の血液を
賦p+2シ九同定の結果判明した。ちなみ14− に、ベースツイン法で求めたHbAICの量は正常人血
3.2%、糖尿病患者血5.9%であつ九。
In addition, it was found that the peak was 4tiHbF as a result of the identification of most of Yuma's blood. By the way, the amount of HbAIC determined by the base twin method was 3.2% in normal human blood and 5.9% in diabetic patient blood.

実施例2 実施例1と同様のカラム、機器、溶離条件で新生児血を
20倍量のイオン交換水と混合して溶血させた水溶液を
試料として分析を行い、第2図に示されるクロマトグラ
ムを得た。該クロ7トグツム中4けHbFであり、極め
てンヤーグに分離されている。
Example 2 Using the same column, equipment, and elution conditions as in Example 1, an aqueous solution prepared by mixing neonatal blood with 20 times the amount of ion-exchanged water to cause hemolysis was analyzed as a sample, and the chromatogram shown in Figure 2 was obtained. Obtained. There are 4 HbF in the 7 black tons, and they are separated very clearly.

実施例3 七ツマ−としてトリノチロールエタントリノタクリレー
)50f及びクロトン酸15tを用い、有機溶媒として
トルエン40fを用いた以外は実施例1と同様圧して充
填剤及び充填カラムを用意し実施例1と同じ試料を用い
、実施例10A液10%とB液90%との混合液を5分
聞流したのちB*に切り替えるという溶離条件で操作し
て第3図に示されるクロマトグツ7を得九。五は正常人
血の、lは糖尿病患者血のクロマトグラムであり、5け
HbAIc、6けHbA・のピークである。この様に*
実施例によれば短時間でHb、Alcの分離が可能であ
った。
Example 3 A packing material and a packed column were prepared under pressure in the same manner as in Example 1, except that 50 f of trinotyrolethane trinotacrylate and 15 t of crotonic acid were used as the sulfuric acid, and 40 f of toluene was used as the organic solvent. Using the same sample as in Example 10 and operating under the elution conditions of flowing a mixture of 10% A solution and 90% B solution for 5 minutes and then switching to B*, chromatograph 7 shown in FIG. 3 was obtained. . 5 is a chromatogram of normal human blood, and 1 is a chromatogram of diabetic patient blood, with the peaks of 5-digit HbAIc and 6-digit HbA·. Like this*
According to the example, it was possible to separate Hb and Alc in a short time.

【図面の簡単な説明】[Brief explanation of drawings]

第1図A社正常人血の、第1図B#′lt糖尿病患者血
0%施例IKおけるタロマドグラム、第2図Fi夾施例
2で得られたクロマトグラム、第3図AFi正常人血の
、第3図BFi糖W病患者血の実施例3におけるクロマ
トグラムを示す。 2・=HbA l m 、 3=HbA 1 b 、 
4・−HbF 。 5−HbA  1  c  、  6−HbAo  、
  7−HbAzの各ピーク。 特許出願人 積水化学工業株式会社 代表者 藤 沼 基 利 第3I11
Figure 1 Talomadogram of company A normal human blood, Figure 1 B#'lt talomadogram of diabetic patient blood 0% Example IK, Figure 2 Fi chromatogram obtained in Example 2, Figure 3 AFi normal human blood. FIG. 3 shows a chromatogram in Example 3 of BFi sugar W disease patient blood. 2.=HbA lm, 3=HbA1b,
4.-HbF. 5-HbA1c, 6-HbAo,
Each peak of 7-HbAz. Patent applicant Sekisui Chemical Co., Ltd. Representative Mototoshi Fujinuma 3I11

Claims (1)

【特許請求の範囲】[Claims] 1 分子中に1個の重合性2型詰合と1個以上のカルボ
キシル基を有し、疎水性/曵うメークーが13以下の重
合性モノマー(2)5〜90重量囁重量子中に2個以上
の重合性2型結合を有しかつ疎水性ノ曵ラメ−ターが2
3以下の架橋重合性七ツマー@10〜9s重量襲、分子
中に1個の重合性2型詰合を有し疎水性パラメーターが
23以下にして上記重合性モノマー囚とけ興なる七ツマ
ー00〜8I重量哄からなるモノマー混合物が共重合さ
れてなる親木性イオン交換体を固定相とする液体クロマ
トグラフィーによって行われることを特徴とする異化ヘ
モグロビンの分離法Φ
1 Polymerizable monomer having one polymerizable type 2 packing and one or more carboxyl groups in the molecule and having a hydrophobicity/hydrophobicity of 13 or less (2) 2 in 5 to 90 weight molecules 2 or more polymerizable type 2 bonds and a hydrophobic polymerization parameter of 2 or more.
Cross-linked polymerizable heptads of 3 or less @ 10-9s weight attack, have one polymerizable type 2 packing in the molecule and have a hydrophobic parameter of 23 or less, and the above-mentioned polymerizable monomers are captured and activated. A method for separating catabolic hemoglobin, characterized in that it is carried out by liquid chromatography using as a stationary phase a woody ion exchanger copolymerized with a monomer mixture consisting of 8I.
JP56099451A 1981-04-27 1981-06-25 Separation of catabolic hemoglobin Granted JPS58760A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP56099451A JPS58760A (en) 1981-06-25 1981-06-25 Separation of catabolic hemoglobin
US06/371,491 US4468330A (en) 1981-04-27 1982-04-23 Filler for liquid chromatography useful for separating a hemoglobin variant in blood
EP82302134A EP0063947B1 (en) 1981-04-27 1982-04-26 Filler for liquid chromatography
DE8282302134T DE3276929D1 (en) 1981-04-27 1982-04-26 Filler for liquid chromatography
CA000401649A CA1203944A (en) 1981-04-27 1982-04-26 Filler for liquid chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56099451A JPS58760A (en) 1981-06-25 1981-06-25 Separation of catabolic hemoglobin

Publications (2)

Publication Number Publication Date
JPS58760A true JPS58760A (en) 1983-01-05
JPH0115024B2 JPH0115024B2 (en) 1989-03-15

Family

ID=14247702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56099451A Granted JPS58760A (en) 1981-04-27 1981-06-25 Separation of catabolic hemoglobin

Country Status (1)

Country Link
JP (1) JPS58760A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02309253A (en) * 1989-05-23 1990-12-25 Sekisui Chem Co Ltd Determination of saccharified hemoglobin
JPH0328400A (en) * 1989-04-10 1991-02-06 Union Carbide Corp Electrolysis for peeling off coating from aluminum base and bath
JPH03102259A (en) * 1989-09-18 1991-04-26 Hitachi Ltd Method, apparatus, system and separation column of liquid chromatograph
JPH03118466A (en) * 1989-09-29 1991-05-21 Sekisui Chem Co Ltd Assay of saccharified hemoglobin
GB2551401A (en) * 2016-06-17 2017-12-20 Keronite International Ltd Durable white inorganic finish for aluminium articles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139684A (en) * 1974-02-01 1979-02-13 Ceskoslovenska Akademie Ved Method for preparation of hydrophilic polymeric ion exchanging gels
US4238196A (en) * 1979-11-01 1980-12-09 Isolab, Inc. Methods to determine a diagnostic indicator of blood sugar conditions, and, liquid chromatographic columns therefor (cyanide free)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139684A (en) * 1974-02-01 1979-02-13 Ceskoslovenska Akademie Ved Method for preparation of hydrophilic polymeric ion exchanging gels
US4238196A (en) * 1979-11-01 1980-12-09 Isolab, Inc. Methods to determine a diagnostic indicator of blood sugar conditions, and, liquid chromatographic columns therefor (cyanide free)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0328400A (en) * 1989-04-10 1991-02-06 Union Carbide Corp Electrolysis for peeling off coating from aluminum base and bath
JPH02309253A (en) * 1989-05-23 1990-12-25 Sekisui Chem Co Ltd Determination of saccharified hemoglobin
JPH087198B2 (en) * 1989-05-23 1996-01-29 積水化学工業株式会社 Quantitative method for glycated hemoglobin
JPH03102259A (en) * 1989-09-18 1991-04-26 Hitachi Ltd Method, apparatus, system and separation column of liquid chromatograph
JPH03118466A (en) * 1989-09-29 1991-05-21 Sekisui Chem Co Ltd Assay of saccharified hemoglobin
GB2551401A (en) * 2016-06-17 2017-12-20 Keronite International Ltd Durable white inorganic finish for aluminium articles
GB2551401B (en) * 2016-06-17 2021-03-03 Keronite International Ltd Durable white inorganic finish for aluminium articles

Also Published As

Publication number Publication date
JPH0115024B2 (en) 1989-03-15

Similar Documents

Publication Publication Date Title
US4468330A (en) Filler for liquid chromatography useful for separating a hemoglobin variant in blood
Roubal et al. Polymerization of proteins induced by free-radical lipid peroxidation
Benson et al. Polymeric columns for liquid chromatography
CN101257969B (en) Hydrophilic polymer microparticle, filler for ion exchange liquid chromatography, and method for production of filler for ion exchange liquid chromatography
EP4275787A1 (en) Vinyl monomer-polyvinyl crosslinking agent copolymer non-porous microsphere, preparation method therfor, and application thereof
SU1311631A3 (en) Tip for liquid chromatography
EP1194479A1 (en) Process for making fluorinated polymer adsorbent particles
JPS58760A (en) Separation of catabolic hemoglobin
JPH0373848A (en) Packing material for liquid chromatography and production thereof
SU1471958A3 (en) Liquid chromatography column and method of filling same
JP3315657B2 (en) Liquid chromatography filter, liquid chromatography column, and method for measuring hemoglobins
JPH03255360A (en) Separation and determination of glycohemoglobin
JPH11295286A (en) Hemoglobins measuring method
Nwaoguikpe et al. The antisickling effects of dried fish (tilapia) and dried prawn (Astacus red)
JP2003107069A (en) Method for measuring hemoglobins
JPS6359463B2 (en)
JPH087198B2 (en) Quantitative method for glycated hemoglobin
JPH03118466A (en) Assay of saccharified hemoglobin
JPS6359464B2 (en)
US7022744B2 (en) Ion exchanger for lipoproteins separation and lipoproteins separation method using the same
JPH01277755A (en) Measuring method of component in blood
JP2004083561A (en) Ion-exchanger for lipoprotein separation, and method for separating lipoprotein using the same
JP5522772B2 (en) Column filler and method for producing column filler
JPS6331737B2 (en)
JPH10227780A (en) Method and device for measuring saccharification hemoglobin